Best Preventive Chlamydia Screening in Kathmandu Catch chlamydia before it causes damage — asymptomatic screening

Overview: Preventive Chlamydia Screening

Chlamydia is the most commonly reported bacterial sexually transmitted infection worldwide, and Nepal is no exception. Caused by Chlamydia trachomatis, it infects the cervix in women and the urethra in men — but up to 70% of infected women and about half of infected men have no symptoms at all. These silent infections can persist for months, damaging reproductive organs and spreading to sexual partners without anyone knowing.

The danger of chlamydia lies in its complications. Untreated infection in women can ascend to the uterus and fallopian tubes, causing pelvic inflammatory disease (PID), tubal scarring, chronic pelvic pain, and infertility. In men, it can cause epididymitis and urethritis. In pregnant women, it increases the risk of preterm delivery and can transmit to the newborn, causing eye and lung infections.

Preventive screening exists precisely because symptoms are unreliable. The CDC and WHO recommend annual chlamydia screening for all sexually active women under 25 and for older women with risk factors such as new partners or multiple partners. Men who have sex with men and anyone with a new or non-monogamous partner should also screen regularly.

At Thamel Clinic, preventive chlamydia screening uses NAAT (nucleic acid amplification testing) — the gold standard molecular test — on urine or swab samples. Results are available within hours to a day, treatment is a simple course of antibiotics when positive, and partner notification support helps prevent reinfection.

What Is Chlamydia and Why Screen Preventively?

Chlamydia is caused by Chlamydia trachomatis, an obligate intracellular bacterium that infects mucosal surfaces — primarily the cervix in women and the urethra in men. It is transmitted through vaginal, anal, and oral sex, and can also pass from mother to baby during childbirth. The bacterium cannot survive outside the body, so transmission requires direct mucosal contact.

What makes chlamydia dangerous is its asymptomatic nature. Most infected people feel completely normal — no discharge, no pain, no obvious sign anything is wrong. Yet the infection silently damages reproductive organs over weeks and months. By the time symptoms appear, complications like pelvic inflammatory disease may already be established.

Preventive screening interrupts this silent progression. A simple urine test can detect infection before symptoms or complications develop, allowing treatment with a short course of antibiotics that cures the infection completely. This is why annual screening is recommended for sexually active young adults — not because symptoms suggest it, but because the absence of symptoms proves nothing.

• Caused by Chlamydia trachomatis — a bacterial STD transmitted through sexual contact.
• Up to 70% of infected women and ~50% of infected men have no symptoms.
• Infects cervix (women), urethra (men), rectum, and throat depending on exposure.
• Can be transmitted from mother to baby during childbirth.
• Silent infection can cause PID, infertility, and chronic pelvic pain.
• Cured completely with antibiotics when detected early.

How Chlamydia Screening Works

The gold standard for chlamydia testing is NAAT (nucleic acid amplification testing), which detects the bacterium's genetic material directly. NAAT is performed on urine samples for both men and women — the first part of the urine stream contains enough organism material for accurate detection. For women, cervical or vaginal swabs can also be used, and throat or rectal swabs are taken if those sites were exposed.

NAAT offers sensitivity and specificity above 95% — far better than older methods like culture or antigen detection. Results are typically available within hours to 24 hours at modern laboratories. At Thamel Clinic, NAAT urine testing is the standard method for chlamydia screening, offering a non-invasive, highly accurate option.

The window period for chlamydia NAAT is approximately 1–2 weeks after exposure — testing too soon can give false-negative results. For recent exposures, repeat testing at 2 weeks is recommended. Annual screening is appropriate for sexually active adults with ongoing risk; more frequent testing may be needed for higher-risk individuals.

• NAAT urine test — first-catch urine sample, non-invasive, over 95% accurate.
• Cervical/vaginal swab — alternative for women when urine testing not possible.
• Rectal and throat swabs — for exposures at those sites.
• Window period — wait 1–2 weeks after exposure before testing.
• Results in hours to 24 hours at modern laboratories.
• No fasting or special preparation needed — just avoid urinating for 1–2 hours before sample.

Who Should Get Preventive Chlamydia Screening?

The CDC recommends annual chlamydia screening for all sexually active women under 25, and for women 25 and older with risk factors — new or multiple partners, inconsistent condom use, or a partner with a known STD. Men who have sex with men should screen every 3–6 months at exposed sites. Anyone diagnosed with another STD should also be tested for chlamydia.

In Nepal, where sexual health screening is not yet routine, preventive chlamydia screening is particularly important for young adults, university students, migrant workers, and anyone with new or multiple partners. Women planning pregnancy should screen before conception to prevent tubal damage and protect the baby.

People with symptoms — discharge, burning urination, pelvic pain, testicular pain — should test immediately rather than waiting for annual screening. But the most important group is those with no symptoms who are at risk: asymptomatic screening is the only way to detect silent infections before they cause complications.

• Sexually active women under 25 — annual screening recommended.
• Women 25+ with new or multiple partners — annual or more frequent screening.
• Men who have sex with men — every 3–6 months at exposed sites.
• Anyone diagnosed with another STD — test for chlamydia too.
• Women planning pregnancy — screen before conception to protect fertility.
• People with symptoms — test immediately, do not wait for annual screening.
• New or non-monogamous partners — test after exposure window (1–2 weeks).

Treatment and Partner Management

Chlamydia is treated with antibiotics — typically azithromycin (single dose) or doxycycline (7-day course). Both are highly effective when taken as prescribed. Patients should complete the full course even if symptoms resolve, and should abstain from sex until treatment is complete and partners are treated.

Partner management is essential for preventing reinfection. All sexual partners from the exposure period should be tested and treated — even if they have no symptoms, because asymptomatic infection is common. The clinic can help with partner notification discreetly, providing information without revealing the patient's identity.

Follow-up testing is recommended 3 months after treatment to confirm cure and detect reinfection. This is especially important if partners were not treated or if the patient has ongoing risk. At Thamel Clinic, treatment, partner notification support, and follow-up testing are integrated into a complete chlamydia management pathway.

• Azithromycin single dose or doxycycline 7-day course — both highly effective.
• Complete the full antibiotic course even if symptoms resolve.
• Abstain from sex until treatment complete and partners treated.
• All partners from exposure period should be tested and treated.
• Partner notification can be done discreetly without revealing identity.
• Follow-up test at 3 months to confirm cure and detect reinfection.

Preventing Chlamydia

There is no vaccine for chlamydia, so prevention relies on safer sex practices and regular screening. Correct and consistent condom use for vaginal, anal, and oral sex significantly reduces transmission risk, though it does not eliminate it entirely because the bacterium can infect areas not covered by condoms.

Limiting sexual partners and knowing both partners' recent STD status lowers risk. For people in ongoing relationships, mutual monogamy after both partners test negative is the most effective prevention strategy. For those with ongoing risk, annual screening provides a safety net.

After treatment, patients should use condoms until follow-up confirms cure and avoid sex with untreated partners. Reinfection is common — studies suggest up to 25% of treated patients acquire chlamydia again within a year, usually from an untreated partner.

• Use condoms correctly for all sexual activity — vaginal, anal, and oral.
• Limit partners and know both partners' STD status before sex.
• Annual screening for sexually active adults with ongoing risk.
• Test after any new partner or unprotected exposure (wait 1–2 weeks).
• Ensure partners are treated before resuming sex after diagnosis.
• Consider mutual testing before unprotected sex in new relationships.

Costs and Access in Kathmandu

Chlamydia NAAT urine testing in Kathmandu typically costs Rs. 1,500–2,500 at private laboratories, with results available within hours to one day. When combined with other STD tests as a panel, costs are lower per test — a full STD panel covering chlamydia, gonorrhea, syphilis, HIV, and hepatitis B runs approximately Rs. 3,500–6,000.

Treatment with azithromycin or doxycycline adds only Rs. 200–500 for the medication course. Partner treatment and follow-up testing are additional but modest costs. At Thamel Clinic, the complete pathway — screening, treatment, partner management, and follow-up — is offered under one roof with transparent pricing.

For patients concerned about privacy, the clinic offers discreet booking, confidential records, and the option of partner notification without revealing identity. Same-day appointments and walk-ins are accepted, and results are delivered digitally for convenience.

• Chlamydia NAAT urine test: Rs. 1,500–2,500 at Kathmandu private labs.
• Full STD panel: Rs. 3,500–6,000 covering chlamydia, gonorrhea, syphilis, HIV, hepatitis B.
• Treatment (azithromycin/doxycycline): Rs. 200–500 for medication course.
• Follow-up test at 3 months: Rs. 1,500–2,500.
• Partner treatment: additional medication cost per partner.
• Same-day appointments and walk-ins accepted at Thamel Clinic.

Chlamydia Screening and Treatment Services

Prices in NPR are indicative; confirm current rates when booking. All services are confidential.

Related Services & Guides